AHA expresses support for KEEP Telehealth Options Act

Jun 19, 2020 - 03:02 PM
computer-closeup-stethoscope-telehealth

The AHA today expressed support for the Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, which would allow the government to study the impact of telehealth during the COVID-19 pandemic and its expanded use. “We greatly appreciate the flexibilities implemented during the public health emergency, as they have allowed hospitals and health systems to care for patients in the comfort and safety of their own homes,” AHA wrote to the bill’s sponsors, Reps. Cynthia Axne, D-Iowa, and Troy Balderson, R-Ohio. In addition, AHA said that “additional data on telehealth uptake and usage is critical to help inform changes that will need to be addressed going forward to ensure patients can continue to access care through telehealth.”

Related News Articles

Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
AHA podcast: Technology That Gives Nurses More Time 
Wendy Kim, DNP, R.N., vice president and chief nursing officer of Henry Ford Health in Michigan, shares how the system’s virtual nursing program is reducing…
Headline
DEA, HHS extend telemedicine waivers through 2026
The Department of Health and Human Services and Drug Enforcement Administration Dec. 30 released a temporary rule extending for the fourth time waiver…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…